The National Cancer Institute (NCI) is offering this grant to fund exploratory research projects focused on the inception and development of early-stage, highly innovative, or emerging technologies for cancer research. This grant is for technologies with significant transformative potential that have not yet been explored in a cancer-relevant context and may require substantial modification for their proposed application. The emphasis is on technical innovation poised to significantly affect and transform investigations into the molecular and cellular bases of cancer. Successful technologies would accelerate or enhance research across cancer biology, prevention, diagnosis, treatment, control, epidemiology, and health disparities, provided they are based on molecular and/or cellular characterizations of cancer.
Opportunity ID: 135253
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-12-002 |
| Funding Opportunity Title: | Early-Stage Innovative Technology Development for Cancer Research (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 21, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 18, 2012 |
| Current Closing Date for Applications: | Sep 18, 2012 |
| Archive Date: | Oct 19, 2012 |
| Estimated Total Program Funding: | $5,000,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education City or township governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education County governments Native American tribal governments (Federally recognized) State governments Special district governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits grant applications proposing exploratory research projects focused on the inception and development of early stage, highly innovative, technologies or emerging technologies with significant transformative potential that has not yet been explored in a cancer-relevant use. An emerging technology is defined (for the purpose of this FOA) as one that has passed the initial developmental stage, but has not yet been evaluated within the context of a cancer-relevant intended use and requires significant modification for the proposed application. The emphasis of this FOA is on technologies with a high degree of technical innovation with the potential to significantly affect and transform investigations exploring the molecular and cellular bases of cancer. If successful, these technologies would accelerate and/or enhance research in the areas of cancer biology, prevention, diagnosis and treatment, control, epidemiology, and/or cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be based on molecular and/or cellular characterizations of cancer. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-002.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | ADOBE-FORMS-B2 | PKG00089372 | Jan 23, 2012 | Sep 18, 2012 | View |
Package 1
Mandatory forms
135253 RR_SF424_1_2-1.2.pdf
135253 PerformanceSite_1_4-1.4.pdf
135253 RR_OtherProjectInfo_1_3-1.3.pdf
135253 RR_KeyPersonExpanded_1_2-1.2.pdf
135253 PHS398_CoverPageSupplement_1_4-1.4.pdf
135253 PHS398_ResearchPlan_1_3-1.3.pdf
135253 PHS398_Checklist_1_3-1.3.pdf
Optional forms
135253 RR_SubawardBudget30-1.2.pdf
135253 PHS398_ModularBudget_1_2-1.2.pdf
135253 RR_Budget-1.1.pdf
135253 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
